Figure 7.

In vivo neutralisation potential of PANAF-Premium antivenom against viperid snake venoms from sSA. The vertical dotted line represents the marketed neutralisation potency of this antivenom against viper venoms highlighted in blue (≥25 LD₅₀s/mL). Additionally, neutralisation potency values in mg/mL against the 3× challenge dose of each venom have also been provided in parentheses. The skull and crossbones symbol indicates complete failure of the antivenom in conferring protection against the N. annulifera venom. The error bars representing the 95% CIs were calculated using probit statistics. The details of antivenom doses (µL), survival patterns, ED₅₀ values and potency values, along with their corresponding 95% CIs, are provided in Table S2B.